ANI Pharmaceuticals reports positive Phase 4 trial results
The SYNCHRONICITY open-label, single-arm Phase 4 clinical trial results were presented as a late-breaking oral presentation at the American Academy of Ophthalmology 2026 Annual Meeting.
Story updates
11:01:50 AM UTC
SquawkNews
ANI Pharmaceuticals reported that its Phase 4 single-arm SYNCHRONICITY trial met both co-primary endpoints at 6 months, with functional and anatomic benefits maintained at 24 months, and a safety profile consistent with prior ILUVIEN studies.Material DetailsContext by AI AnalystThis is post-approva…